Resources

Type of publications
Regions
Diseases

5192 results found

2023 ∙ Tayebi, A. Samimisedeh, P. Jafari Afshar, E. Mahmoudnia, S. Milan, N. Ayati, A. Madady, A. Rastad, H.

Neuromuscular diseases associated with COVID-19 vaccines: a systematic review and pooled analysis of 258 patients

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Potestio, L. Battista, T. Cacciapuoti, S. Ruggiero, A. Martora, F. Fornaro, L. Camela, E. Megna, M.

New Onset and Exacerbation of Psoriasis Following COVID-19 Vaccination: A Review of the Current Knowledge

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Harel, T. Gorman, E. F. Wallin, M. T.

New onset or relapsing neuromyelitis optica temporally associated with SARS-CoV-2 infection and COVID-19 vaccination: a systematic review

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Arifin, A. N. F. Hengky, A. Widjaja, M. Wijaya, L.

New-Onset and Exacerbation of Psoriasis following COVID-19 Vaccination: A Systematic Review of Case Reports and Case Series

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Liu, J. Wu, H. Xia, S. L.

New-Onset Arthritis Following COVID-19 Vaccination: A Systematic Review of Case Reports

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Nune, A. Durkowski, V. Pillay, S. S. Barman, B. Elwell, H. Bora, K. Bilgrami, S. Mahmood, S. Babajan, N. Venkatachalam, S. Ottewell, L. Manzo, C.

New-Onset Rheumatic Immune-Mediated Inflammatory Diseases Following SARS-CoV-2 Vaccinations until May 2023: A Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Geraghty, K. Rooney, D. Watson, C. Ledwidge, M. T. Glynn, L. Gallagher, J.

Non-specific effects of Pneumococcal and Haemophilus vaccines in children aged 5 years and under: a systematic review

  • Newborn
  • Children
  • Pneumococcal disease
  • Haemophilus influenzae type B
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2023 ∙ Di Spirito, F. Pantaleo, G. Di Palo, M. P. Amato, A. Raimondo, A. Amato, M.

Oral Human Papillomavirus Benign Lesions and HPV-Related Cancer in Healthy Children: A Systematic Review

  • Adolescents
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Puspitasari, M. Sattwika, P. D. Rahari, D. S. Wijaya, W. Hidayat, A. R. P. Kertia, N. Purwanto, B. Thobari, J. A.

Outcomes of vaccinations against respiratory diseases in patients with end-stage renal disease undergoing hemodialysis: A systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Ishisaka, Y. Watanabe, A. Aikawa, T. Kanaoka, K. Takagi, H. Wiley, J. Yasuhara, J. Kuno, T.

Overview of SARS-CoV-2 infection and vaccine associated myocarditis compared to non-COVID-19-associated myocarditis: A systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...